Fisher & Paykel Healthcare Corporation Limited (FPH), listed on the New Zealand and Australian stock exchanges, today provided revenue and net profit after tax guidance for the first half of the 2023 financial year ending 30 September 2022.
At current exchange rates and assuming a continuation of trading conditions in the first four months, the company expects operating revenue of approximately $670 million and net profit after tax of approximately $85 million to $95 million.
This guidance is subject to potential impacts of the COVID-19 pandemic and customer inventory levels, as well as manufacturing inefficiencies.
FPH is targeting 10% constant currency operating expense growth for the year.
The Annual Shareholders’ Meeting is scheduled for 24 August.
See more
